Search Results - "Hajarizadeh, Behzad"

Epidemiology and natural history of HCV infection by Hajarizadeh, Behzad, Grebely, Jason, Dore, Gregory J.

“…Globally, 130–170 million people have HCV infection; however, distribution patterns are highly variable. This Review outlines the latest information on the…”
Get full text

Direct-acting antiviral agents for HCV infection affecting people who inject drugs by Grebely, Jason, Hajarizadeh, Behzad, Dore, Gregory J.

“…Key Points HCV prevalence and incidence among people who inject drugs (PWID) remains high Direct-acting antiviral agents (DAA) for HCV with cure in >95%…”
Get full text

Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis by Hajarizadeh, Behzad, Cunningham, Evan B., Valerio, Heather, Martinello, Marianne, Law, Matthew, Janjua, Naveed Z., Midgard, Håvard, Dalgard, Olav, Dillon, John, Hickman, Matthew, Bruneau, Julie, Dore, Gregory J., Grebely, Jason

“…HCV reinfection following successful treatment can compromise treatment outcomes. This systematic review assessed the rate of HCV reinfection following…”
Get full text

Impact of Shave Biopsy on Diagnosis and Management of Cutaneous Melanoma: A Systematic Review and Meta-Analysis by Ahmadi, Omid, Das, Moushumi, Hajarizadeh, Behzad, Mathy, Jon A.

“…Background Melanoma is the most lethal skin cancer. Excision biopsy is generally recommended for clinically suspicious pigmented lesions; however, a proportion…”
Get full text

Direct-acting antiviral treatment for hepatitis C among people who use or inject drugs: a systematic review and meta-analysis by Hajarizadeh, Behzad, Cunningham, Evan B, Reid, Hannah, Law, Matthew, Dore, Gregory J, Grebely, Jason

“…There are concerns around poorer response to direct-acting antiviral (DAA) therapy for hepatitis C virus infection among people who use drugs. This systematic…”
Get more information

Management of acute HCV infection in the era of direct-acting antiviral therapy by Martinello, Marianne, Hajarizadeh, Behzad, Grebely, Jason, Dore, Gregory J., Matthews, Gail V.

“…The management of acute HCV infection has not been standardized following the availability of direct-acting antiviral agents (DAAs) for chronic HCV infection,…”
Get full text

Australia could miss the WHO hepatitis C virus elimination targets due to declining treatment uptake and ongoing burden of advanced liver disease complications by Kwon, Jisoo A, Dore, Gregory J, Hajarizadeh, Behzad, Alavi, Maryam, Valerio, Heather, Grebely, Jason, Guy, Rebecca, Gray, Richard T

“…Australia was one of the first countries to introduce government-funded unrestricted access to direct-acting antiviral (DAA) therapy, with 88,790 treated since…”
Get full text

Hepatitis B knowledge and associated factors among people with chronic hepatitis B by Hajarizadeh, Behzad, Wallace, Jack, Richmond, Jacqui, Ngo, Naomi, Enright, Chris

“…To assess hepatitis B knowledge among people with chronic hepatitis B (CHB) in Australia. People with CHB in three Australian jurisdictions completed a…”
Get full text

Timely Hepatitis C RNA Testing and Treatment in the Era of Direct-Acting Antiviral Therapy among People with Hepatitis C in New South Wales, Australia by Yousafzai, Mohammad T., Alavi, Maryam, Valerio, Heather, Hajarizadeh, Behzad, Grebely, Jason, Dore, Gregory J.

“…This study aimed to identify the factors associated with timely (within four weeks) HCV RNA testing and timely (within six months) DAA initiation following HCV…”
Get full text

Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre‐ and post‐universal access to direct‐acting antiviral treatment in Australia: The LiveRLife study by Bajis, Sahar, Grebely, Jason, Hajarizadeh, Behzad, Applegate, Tanya, Marshall, Alison D., Ellen Harrod, Mary, Byrne, Jude, Bath, Nicky, Read, Phillip, Edwards, Michael, Gorton, Carla, Hayllar, Jeremy, Cock, Victoria, Peterson, Steven, Thomson, Claire, Weltman, Martin, Jefferies, Meryem, Wood, William, Haber, Paul, Ezard, Nadine, Martinello, Marianne, Maher, Lisa, Dore, Gregory J., Peolim, Lucy, How‐Chow, Dianne, Telenta, Jo, Harvey, Paul, Jones, Sandra, Dunlop, Adrian, Treloar, Carla, Samuel, Yvonne, Poeder, Fiona, Crawford, Sione, Baxter, Alicia, Keats, Julian, Mowat, Yasmin, Silk, David, Micallef, Michelle, Tamaddoni, Mahshid, Marks, Pip, Lamoury, Francois, Jayasinghe, Indika, Reid, Hannah, Cunningham, Evan B., Bartlett, Sofia, Jacka, Brendan, Erratt, Amanda, Jauncey, Marianne, Collie, Patricia, Lam, Thao, Gilliver, Rosemary, Hazelwood, Susan, Houlihan, Nives, Burns, Carina, Lewis, Rhondda, Morris, Daniel, Donohue, Kathy, Carthew, Astrid, Horasak, Nadine, Cherry, Robert, Shin, Sue, Peterson, Deborah, Sellwood, Todd, McKeown, Wade, Pritchard‐Jones, Janice, Smyth, Fionnualh, Adey, Sara, Clark, Kathy

“…Gaps in hepatitis C virus (HCV) testing, diagnosis, liver disease assessment and treatment uptake among people who inject drugs (PWID) persist. We aimed to…”
Get full text

Hepatitis C virus testing, liver disease assessment and direct‐acting antiviral treatment uptake and outcomes in a service for people who are homeless in Sydney, Australia: The LiveRLife homelessness study by Bajis, Sahar, Grebely, Jason, Cooper, Lucy, Smith, Julie, Owen, Greg, Chudleigh, Alan, Hajarizadeh, Behzad, Martinello, Marianne, Adey, Sara, Read, Phillip, Gilliver, Rosemary, Applegate, Tanya, Treloar, Carla, Maher, Lisa, Dore, Gregory J.

“…People who are homeless have increased hepatitis C virus (HCV) infection risk, and are less likely to access primary healthcare. We aimed to evaluate HCV RNA…”
Get full text

Understanding how to live with hepatitis B: a qualitative investigation of peer advice for Chinese people living with hepatitis B in Australia by Wallace, Jack, Xiao, Yinzong, Howell, Jess, Thompson, Alex, Allard, Nicole, Adamson, Emily, Richmond, Jacqui, Hajarizadeh, Behzad, Eagle, Melanie, Doyle, Joseph, Hellard, Margaret

“…Hepatitis B is a chronic viral infection, a leading cause of primary liver cancer and identified as a major public health priority by the World Health…”
Get full text

Challenges in managing patients in Australia with chronic hepatitis B: the General Practitioners’ perspective by Wallace, Jack, Hajarizadeh, Behzad, Richmond, Jacqui, McNally, Stephen

“…General Practitioners (GPs) are essential to reducing the impact of chronic hepatitis B (CHB) given their clinical management role where only 56% of people…”
Get full text

Elimination of Hepatitis C Virus in Australia by Dore, Gregory J., BSc, MBBS, MPH, FRACP, PhD, Hajarizadeh, Behzad, MD, MPH, PhD

“…Australia is on-track to achieve World Health Organization hepatitis C virus (HCV) elimination targets. An active HCV screening program led to 82% of…”
Get full text

Economic evaluation of pan-genotypic generic direct-acting antiviral regimens for treatment of chronic hepatitis C in Iran: a cost-effectiveness study by Tasavon Gholamhoseini, Mohammad, Sharafi, Heidar, HL Borba, Helena, Alavian, Seyed Moayed, Sabermahani, Asma, Hajarizadeh, Behzad

“…IntroductionLow-cost generic direct-acting antiviral (DAA) regimens for treatment of hepatitis C virus (HCV) are available in several low-income/middle-income…”
Get full text

Exploring the Public Health and Social Implications of Future Curative Hepatitis B Interventions by Wallace, Jack, Richmond, Jacqueline, Howell, Jessica, Hajarizadeh, Behzad, Power, Jennifer, Treloar, Carla, Revill, Peter A, Cowie, Benjamin, Wang, Su, Stoové, Mark, Pedrana, Alisa, Hellard, Margaret

“…Hepatitis B is a significant global health issue where the 296 million people estimated to live with the infection risk liver disease or cancer without…”
Get full text

Mortality trends among people with hepatitis B and C: a population-based linkage study, 1993-2012 by Alavi, Maryam, Grebely, Jason, Hajarizadeh, Behzad, Amin, Janaki, Larney, Sarah, Law, Matthew G, George, Jacob, Degenhardt, Louisa, Dore, Gregory J

“…This study evaluated cause-specific mortality trends including liver-related mortality among people with a hepatitis B virus (HBV) and hepatitis C virus (HCV)…”
Get full text

A Testing Campaign Intervention Consisting of Peer-Facilitated Engagement, Point-of-Care HCV RNA Testing, and Linkage to Nursing Support to Enhance Hepatitis C Treatment Uptake among People Who Inject Drugs: The ETHOS Engage Study by Conway, Anna, Valerio, Heather, Alavi, Maryam, Silk, David, Treloar, Carla, Hajarizadeh, Behzad, Marshall, Alison D, Martinello, Marianne, Milat, Andrew, Dunlop, Adrian, Murray, Carolyn, Prain, Bianca, Henderson, Charles, Amin, Janaki, Read, Phillip, Marks, Pip, Degenhardt, Louisa, Hayllar, Jeremy, Reid, David, Gorton, Carla, Lam, Thao, Christmass, Michael, Wade, Alexandra, Montebello, Mark, Dore, Gregory J, Grebely, Jason

“…This study evaluated HCV treatment initiation among people who inject drugs (PWID) following an intervention of campaign days involving peer connection,…”
Get full text

Evaluation of a Hepatitis C Virus Core Antigen Assay in Plasma and Dried Blood Spot Samples by Lamoury, François M.J., Hajarizadeh, Behzad, Soker, Angelica, Martinez, Danica, Quek, Camelia, Cunningham, Philip, Catlett, Beth, Cloherty, Gavin, Marks, Philippa, Amin, Janaki, Grebely, Jason, Dore, Gregory J., Applegate, Tanya L.

“…Simplified, affordable tools to diagnose active hepatitis C virus (HCV) infection are needed to scale up treatment. This study evaluated the analytical…”
Get full text

Managing chronic hepatitis B: A qualitative study exploring the perspectives of people living with chronic hepatitis B in Australia by Wallace, Jack, McNally, Stephen, Richmond, Jacqui, Hajarizadeh, Behzad, Pitts, Marian

“…The implementation of a comprehensive public health response to hepatitis B in Australia is urgently required to reduce the increasing burden of hepatitis B…”
Get full text